The product is not meeting the antigen excess protection claim of up to 760mg/L, as stated in the Instructions for Use.
Source facts
Action
The recalling firm notified their U.S. location by letter dated 3/6/2018 via email on 3/9/2018.
Initiated
2018-03-09
Root cause
Under Investigation by firm
Terminated
2020-06-22
Distribution
US Distribution was made to CA. There was no foreign/military/government distribution.
Recall number
Z-1301-2018
Recall status
Terminated
CDRH record ID
162483
FDA record created
2018-04-03
Recall event number
79499
Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.
Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.